What is retrolet fibroplasia?
Retroletary fibroplasia, also known as retinopathy of premature (ROP), is a rare disease in which blood vessels grow abnormally behind the retina. In serious cases, this proceeds to the scar tissue that can lead to eye problems. Retroletary fibroplasia occurs in premature infants and was associated with high oxygen concentrations used to support their insufficiently developed lungs.
In the fetus, blood vessels begin to form in the eye three months after conception and are complete after birth. Premature this development disrupts and often causes vascular proliferation of the retina. Severe retrolet fibroplasia is marked by this rapid growth and severe scarring and occasionally by the retinal department. This can lead to blindness, reduce vision and other eye problems.
Which premature children are at most the risk of developing retroleret fibroplasia? The risk is proportional to how premature the child is, which means that the sooner they were born, the Thvy's chances of developing the disease. Also smaller PREmies, regardless of gestational age, are at higher risk. Because retrolet fibroplasia is such serious diseases, most, if not all children born 34 weeks ago gestational age, three weeks in the short period, are projected by an ophthalmologist.
What are the symptoms of retrolet fibroplasia? Unfortunately, most of the symptoms of the disease are not noticeable for the untrained eye. Symptoms include white pupils (leukocoria), abnormal eye movement (nystagmus), severe myopia (nearsightedness) and crossed eyes (strabismus). It is necessary to recover that these diseases are diagnosed and treated early before serious scarring and retina separate.
Treatment of retrolet fibroplasia includes cryotherapy or freezing therapy, surgery for re -treatment of retinal, laser treatment and low vision support. Los Angeless therapy is used more often than cryotherapy but must be used a premiumBefore serious scarring and retinal separation occur. There were studies on premature infants using oral vitamin E, which showed a reduction in the occurrence of retrolet fibroplasia. Abnormal blood vessel growth usually becomes normal in itself, but approximately 10% of the affected infants will continue to experience abnormal growth and progress to severe retroly fibroplasia.
There are little to do to prevent retrolet fibroplasia except premature birth. Early diagnosis and treatment are key to preventing great eye damage. Since neonatal intensive care units are increasingly top, doctors can more effectively monitor the oxygen level supplied to the premiums, reducing the potential for the development of the disease.